May 7, 2020 / 12:06 PM / 21 days ago

BRIEF-Kala Pharmaceuticals Reports Q1 Loss Per Share $0.54

May 7 (Reuters) - Kala Pharmaceuticals Inc:

* KALA PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 REVENUE ESTIMATE $2.7 MILLION — REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE ESTIMATE $-0.51 — REFINITIV IBES DATA

* KALA PHARMACEUTICALS - ANTICIPATES EXISTING CASH RESOURCES WILL ENABLE IT TO FUND OPERATIONS INTO AT LEAST Q2 OF 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below